Financial reports and presentations

05 August 24

Q2, Interim Report

16 May 24

Redeye Investor Forum

29 April 24

Annual Report 2023

29 April 24

Q1, Interim Report

17 April 24

Life Science Day 2024

12 March 24

Swiss Nordic Bio Conference, interview with Immunovia CEO Jeff Borcherding and BioStock

21 February 24

Full Year Report, 2023

09 November 23

Q3, Interim Report

30 August 23

Q2, Interim Report

11 July 23

Immunovia’s conference call related to the changes announced on July 11

23 May 23

Q1, Interim Report

03 May 23

Immunovia Webcast – Panel Discussions: Adoption of IMMray™ PanCan-d

21 April 23

Annual Report, 2022

23 February 23

Full Year Report, 2022

01 December 22

Erik Penser – Healthcare Day

16 November 22

Jefferies London Healthcare Conference

10 November 22

Q3, Interim Report

31 August 22

Gilmartin Group Emerging Growth Conference

24 August 22

Q2, Interim Report

27 June 22

Immunovia’s Presentation of PanFAM-1 Results

28 April 22

Q1, Interim Report

09 March 22

Cowen’s 42nd Annual Health Care Conference

10 March 22

Annual Report, 2021

17 February 22

Full Year Report, 2021

02 December 21

Erik Penser Bank’s Life Science Day

11 November 21

Q3, Interim Report

12 October 21

Vator Securities Healthcare Innovation Summit

26 August 21

Erik Penser Banks Bolagsdag

19 August 21

Q2, Interim Report

10 June 21

Key Opinion Leader Event

28 April 21

Q1, Interim Report

30 March 21

Blinded clinical validation of IMMray™ PanCan-d (Webinar 4)

20 March 21

Annual Report, 2020

17 February 21

Full Year Report, 2020

17 December 20

Clinical verification of IMMray™ PanCan-d (Webinar 3)

08 December 20

Interview with Prof. Stephen Pereira

18 November 20

Jefferies London Healthcare Conference

12 November 20

Q3, Interim Report

30 November 20

Introducing New CEO

14 September 20

H.C. Wainwright 22nd Annual Global Investment Conference

20 August 20

Q2, Interim Report

30 June 20

Virtual Investor Day

20 May 20

Immunovia Corporate Presentation May 2020

28 April 20

Q1, Interim Report

19 March 20

Annual Report, 2019

14 February 20

Full Year Report, 2019

27 November 19

Vator Securities Unicorn Summit

08 November 19

Q3, Interim Report

23 August 19

Q2, Interim Report

29 April 19

Q1, Interim Report

24 March 19

Carnegie Healthcare Seminar

21 March 19

Vator Securities Unicorn Summit

04 March 19

Annual Report, 2018

14 February 19

Full Year Report, 2018

07 November 18

Q3, Interim Report

24 August 18

Q2, Interim Report

27 April 18

Q1, Interim Report

03 April 18

Nasdaq Stockholm welcomes Immunovia to the main market

19 March 18

Annual Report, 2017

15 February 18

Full year report, 2017

13 November 17

Q3, Interim Report

23 August 17

Q2, Interim Report

20 April 17

Q1, Interim Report

23 March 17

Annual Report, 2016

15 February 17

Full year report, 2016

13 December 16

Avanza Interview

17 November 16

Star of Innovation award winner

24 August 16

Q2, Interim Report

04 April 16

Annual Report, 2015

24 February 16

Full Year Report, 2015

13 May 15

Annual Report, 2014

14 April 14

Annual Report, 2013